Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Nov-Dec;83(6):602-10.
doi: 10.1007/BF01906954.

Recruitment of inotropic reserve in "stunned" myocardium by the cardiotonic agent AR-L 57

Affiliations

Recruitment of inotropic reserve in "stunned" myocardium by the cardiotonic agent AR-L 57

G Heusch et al. Basic Res Cardiol. 1988 Nov-Dec.

Abstract

Contractile dysfunction of reversibly injured, reperfused myocardium can be enhanced by inotropic interventions. A decrease in the Ca-sensitivity of contractile proteins with slow recovery during reperfusion has been suggested as a potential mechanism underlying this postischemic dysfunction. We therefore tested the effects of the cardiotonic agent AR-L 57 (1 mg/kg i.v.) in six anesthetized, vagotomized dogs during constant atrial pacing at 192 +/- 6 beats/min. Before ischemia, AR-L 57 increased left ventricular pressure from 131 +/- 22 to 138 +/- 21 mm Hg and maximum dP/dt from 3,022 +/- 1,427 to 4,337 +/- 2,608 mm Hg/s. Mean systolic thickening velocity of the posterior myocardium was increased from 8.9 +/- 1.1 to 11.7 +/- 1.1 mm/s. After release of a 15 min LCX-occlusion which caused complete regional akinesia, baseline function in the posterior myocardium was severely depressed and only gradually returned towards control values over 8 h of reperfusion. AR-L 57 increased systolic thickening velocity at 10 min, 4 and 8 h reperfusion to a similar extent as before ischemia. With reference to a purported Ca-sensitizing mechanism underlying the positive inotropic action of AR-L 57, our data suggest no change in the Ca-sensitivity of reperfused myocardium.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Cardiol. 1985 Dec 1;56(15):964-8 - PubMed
    1. Arzneimittelforschung. 1981;31(1a):141-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1980 Sep;77(9):5471-5 - PubMed
    1. Eur J Clin Pharmacol. 1976 Sep 30;10(5):319-24 - PubMed
    1. Circulation. 1986 Mar;73(3 Pt 2):III99-108 - PubMed

Publication types

LinkOut - more resources